Does ALTEPLASE Cause Cardiogenic shock? 59 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 59 reports of Cardiogenic shock have been filed in association with ALTEPLASE (Activase). This represents 0.5% of all adverse event reports for ALTEPLASE.
59
Reports of Cardiogenic shock with ALTEPLASE
0.5%
of all ALTEPLASE reports
38
Deaths
19
Hospitalizations
How Dangerous Is Cardiogenic shock From ALTEPLASE?
Of the 59 reports, 38 (64.4%) resulted in death, 19 (32.2%) required hospitalization, and 10 (16.9%) were considered life-threatening.
Is Cardiogenic shock Listed in the Official Label?
Yes, Cardiogenic shock is listed as a known adverse reaction in the official FDA drug label for ALTEPLASE.
What Other Side Effects Does ALTEPLASE Cause?
No adverse event (2,456)
Off label use (1,752)
Gingival bleeding (1,018)
Cerebral haemorrhage (819)
Death (818)
Haemorrhage intracranial (615)
Angioedema (603)
Haemorrhage (536)
Drug ineffective (524)
Haemorrhagic transformation stroke (496)
What Other Drugs Cause Cardiogenic shock?
AMLODIPINE (779)
AMIODARONE (595)
BUPROPION (559)
ACETAMINOPHEN (466)
METOPROLOL (454)
BISOPROLOL (413)
VERAPAMIL (412)
NOREPINEPHRINE (381)
HEPARIN (357)
METFORMIN (356)
Which ALTEPLASE Alternatives Have Lower Cardiogenic shock Risk?
ALTEPLASE vs ALTERNARIA ALTERNATA
ALTEPLASE vs ALTHIAZIDE
ALTEPLASE vs ALTHIAZIDE\SPIRONOLACTONE
ALTEPLASE vs ALUMINUM
ALTEPLASE vs ALUMINUM HYDROXIDE